Vendor, Radeberg, DEU
Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH
UEI LAHNMPWWFFJ9, CAGE CD963
1 award and $11,210 obligated between March 26, 2024 and March 26, 2024, 0% under full and open competition, against 1.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Competed Under SAP | 1 |
| Purchase Order | 1 |
Hear when Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH wins an award and when a contract it holds is about to end.Follow it
Contracts ending soon
None of Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH's contracts with a published end date ends in the next 19 months.
Competes with
Vendors selling medicinal and botanical manufacturing to National Institutes of Health, by dollars.
| Bachem Americas Inc.Torrance, CA | $155,748 |
| US Specialty Formulations LLCAllentown, PA | $71,875 |
| Rotem Inc.Topsfield, MA | $39,445 |
| Concept to Market LLCMonrovia, MD | $0 |
| Regis Technologies Inc.Morton Grove, IL | -$48 |
| United Oxygen Company, Inc.Frederick, MD | -$10,561 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95024P00191Purchase Order, March 26, 2024, Competed Under SAP, 1 offers | National Institutes of Health NidaNational Institutes of Health | Pots 24-2260. Custom Order,sdm-8 Tin Precursor 200 MG Per Vial(R)-Sdm-8 Standard10 MG Per Vial(S)-Sdm-8 Standard5 MG Per VialNAICS 325411, PSC Q301 | $11,210 |
- Places of performance
- Maryland
- Product and service codes
- Q301 Reference Laboratory Testing
- Transactions
- 1 across 1 awards